Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1985 Aug;61(2):459–466.

Numerical and functional alterations in circulatory lymphocytes in cigarette smokers.

D A Hughes, P L Haslam, P J Townsend, M Turner-Warwick
PMCID: PMC1577295  PMID: 2931227

Abstract

Simultaneous numerical and functional studies of circulatory lymphocytes were undertaken in healthy non-smoking and cigarette-smoking volunteers. The smokers all had light to moderate histories of less than 50 pack years. By contrast with non-smokers (n = 32), the smokers (n = 14) had a significant increase in the total number of lymphocytes, surface immunoglobulin bearing (sIg+) cells, total T-cells (T3+) and T helper-inducer cells (T4+), and a trend of increase in T suppressor-cytotoxic cells (8+). These changes differ from those in heavy smokers who have been reported to show significantly increased T suppressor-cytotoxic but significantly decreased T helper-inducer cells. Although the proportions of T-cell subsets did not differ significantly in the light to moderate smokers compared with non-smokers, in vitro T-suppressor function against the Ig-secreting response of allogeneic B-cells to pokeweed mitogen (PWM) stimulation was significantly impaired. The proliferative response of T-cells to phytohaemagglutinin (PHA) was, however, similar in both groups. This suggests that smoking may exert a selective influence upon a subset of T suppressor cells. In cytotoxicity assays, smokers showed a significant decrease in natural killer cell (NK) activity but not in antibody dependent cellular cytotoxicity (ADCC). It appears that these alterations are reversible since a group of ex-smokers (n = 10) were indistinguishable from our non-smoking group in all studies. The implications regarding the link between smoking and increased susceptibility to infection and malignancy are discussed; and these findings should be borne in mind in basic studies of lymphocytes.

Full text

PDF
459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Doll R., Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J. 1976 Dec 25;2(6051):1525–1536. doi: 10.1136/bmj.2.6051.1525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ferson M., Edwards A., Lind A., Milton G. W., Hersey P. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer. 1979 May 15;23(5):603–609. doi: 10.1002/ijc.2910230504. [DOI] [PubMed] [Google Scholar]
  3. Finklea J. F., Sandifer S. H., Smith D. D. Cigarette smoking and epidemic influenza. Am J Epidemiol. 1969 Nov;90(5):390–399. doi: 10.1093/oxfordjournals.aje.a121084. [DOI] [PubMed] [Google Scholar]
  4. Friedman G. D., Siegelaub A. B., Seltzer C. C., Feldman R., Collen M. F. Smoking habits and the leukocyte count. Arch Environ Health. 1973 Mar;26(3):137–143. doi: 10.1080/00039896.1973.10666241. [DOI] [PubMed] [Google Scholar]
  5. Gerrard J. W., Heiner D. C., Ko C. G., Mink J., Meyers A., Dosman J. A. Immunoglobulin levels in smokers and non-smokers. Ann Allergy. 1980 May;44(5):261–262. [PubMed] [Google Scholar]
  6. Ginns L. C., Goldenheim P. D., Miller L. G., Burton R. C., Gillick L., Colvin R. B., Goldstein G., Kung P. C., Hurwitz C., Kazemi H. T-lymphocyte subsets in smoking and lung cancer: Analysis of monoclonal antibodies and flow cytometry. Am Rev Respir Dis. 1982 Aug;126(2):265–269. doi: 10.1164/arrd.1982.126.2.265. [DOI] [PubMed] [Google Scholar]
  7. Haslam P. L., Allan F., Watling A. F., Barrett C., Morris L., Turner-Warwick M. Impaired antibody-dependent cell-mediated cytotoxicity in cryptogenic fibrosing alveolitis (synonym: idiopathic pulmonary fibrosis). Clin Exp Immunol. 1982 Jul;49(1):59–66. [PMC free article] [PubMed] [Google Scholar]
  8. Herscowitz H. B., Sakane T., Steinberg A. D., Green I. Heterogeneity of human suppressor cells induced by concanavalin A as determined in simultaneous assays of immune function. J Immunol. 1980 Mar;124(3):1403–1410. [PubMed] [Google Scholar]
  9. Hersey P., Prendergast D., Edwards A. Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking. Med J Aust. 1983 Oct 29;2(9):425–429. [PubMed] [Google Scholar]
  10. Jondal M., Spine C., Targan S. Human spontaneous killer cells selective for tumour-derived target cells. Nature. 1978 Mar 2;272(5648):62–64. doi: 10.1038/272062a0. [DOI] [PubMed] [Google Scholar]
  11. Kung P., Goldstein G., Reinherz E. L., Schlossman S. F. Monoclonal antibodies defining distinctive human T cell surface antigens. Science. 1979 Oct 19;206(4416):347–349. doi: 10.1126/science.314668. [DOI] [PubMed] [Google Scholar]
  12. Meuer S. C., Hussey R. E., Penta A. C., Fitzgerald K. A., Stadler B. M., Schlossman S. F., Reinherz E. L. Cellular origin of interleukin 2 (IL 2) in man: evidence for stimulus-restricted IL 2 production by T4+ and T8+ T lymphocytes. J Immunol. 1982 Sep;129(3):1076–1079. [PubMed] [Google Scholar]
  13. Miller L. G., Goldstein G., Murphy M., Ginns L. C. Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry. Chest. 1982 Nov;82(5):526–529. doi: 10.1378/chest.82.5.526. [DOI] [PubMed] [Google Scholar]
  14. Moretta L., Mingari M. C., Sekaly P. R., Moretta A., Chapuis B., Cerottini J. C. Surface markers of cloned human T cells with various cytolytic activities. J Exp Med. 1981 Aug 1;154(2):569–574. doi: 10.1084/jem.154.2.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Onari K., Seyama A., Inamizu T., Kodomari N., Takaishi M., Yorioka N., Ikuta T., Iwamoto K., Sadamoto K., Katsube M. Immunological study on cigarette smokers. Part I. Serum protein pattern in smokers. Hiroshima J Med Sci. 1978 Jun;27(2):113–118. [PubMed] [Google Scholar]
  16. Reinherz E. L., Kung P. C., Goldstein G., Levey R. H., Schlossman S. F. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. Proc Natl Acad Sci U S A. 1980 Mar;77(3):1588–1592. doi: 10.1073/pnas.77.3.1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Reinherz E. L., Kung P. C., Goldstein G., Schlossman S. F. Further characterization of the human inducer T cell subset defined by monoclonal antibody. J Immunol. 1979 Dec;123(6):2894–2896. [PubMed] [Google Scholar]
  18. Reinherz E. L., Schlossman S. F. Current concepts in immunology: Regulation of the immune response--inducer and suppressor T-lymphocyte subsets in human beings. N Engl J Med. 1980 Aug 14;303(7):370–373. doi: 10.1056/NEJM198008143030704. [DOI] [PubMed] [Google Scholar]
  19. Riccardi C., Santoni A., Barlozzari T., Puccetti P., Herberman R. B. In vivo natural reactivity of mice against tumor cells. Int J Cancer. 1980 Apr 15;25(4):475–486. doi: 10.1002/ijc.2910250409. [DOI] [PubMed] [Google Scholar]
  20. Silverman N. A., Potvin C., Alexander J. C., Jr, Chretien P. B. In vitro lymphocyte reactivity and T-cell levels in chronic cigarette smokers. Clin Exp Immunol. 1975 Nov;22(2):285–292. [PMC free article] [PubMed] [Google Scholar]
  21. Thomas W. R., Holt P. G., Keast D. Recovery of immune system after cigarette smoking. Nature. 1974 Mar 22;248(446):358–359. doi: 10.1038/248358a0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES